Skip to main content
. 2024 Jan 22;42(9):1021–1030. doi: 10.1200/JCO.23.01498

FIG 2.

FIG 2.

Kaplan-Meier curves plotting the probability of (A) PFS and (B) OS among kidney transplant recipients with advanced cutaneous squamous cell carcinoma receiving cemiplimab. OS, overall survival; PFS, progression-free survival.